Danaparoid: An anti-thrombotic agent without major impact on triglyceride hydrolysis capacity in humans [2]

Journal of Internal Medicine

Volumn 244, Issue 2, 1998, Pages 184-

  Mikhailidis, D P ^a   Jagroop, I A ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DANAPAROID; FATTY ACID; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

DRUG SAFETY; FATTY ACID BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; HYPERTRIGLYCERIDEMIA; INTRAVENOUS DRUG ADMINISTRATION; LETTER; LIPOLYSIS; NORMAL HUMAN; PRIORITY JOURNAL;

ANTICOAGULANTS; ANTITHROMBIN III; CHONDROITIN SULFATES; DERMATAN SULFATE; DRUG COMBINATIONS; FATTY ACIDS, NONESTERIFIED; HEPARINOIDS; HEPARITIN SULFATE; HUMANS; HYDROLYSIS; TRIGLYCERIDES;

EID: 0031880876     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.1998.0371b.x     Document Type: Letter

References (5)